These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7650228)

  • 21. A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes.
    Frye LJ; Byrne ME; Winikoff B
    Eur J Contracept Reprod Health Care; 2016 Aug; 21(4):265-8. PubMed ID: 27102981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function.
    Johnson HJ; Swan SK; Heim-Duthoy KL; Nicholls AJ; Tsina I; Tarnowski T
    Clin Pharmacol Ther; 1998 May; 63(5):512-8. PubMed ID: 9630824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of minoxidil in patients with various degrees of renal function.
    Halstenson CE; Opsahl JA; Wright CE; Fleishaker JC; Andreadis NA; Sobieraj J; Matzke GR
    J Clin Pharmacol; 1989 Sep; 29(9):798-802. PubMed ID: 2808745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
    Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition and safety of omapatrilat in subjects with renal impairment.
    Sica DA; Liao W; Gehr TW; Khan S; Jemal M; Delaney CL; Ferreira IM; Malhotra BK
    Clin Pharmacol Ther; 2000 Sep; 68(3):261-9. PubMed ID: 11014407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of fluconazole in renal failure.
    Berl T; Wilner KD; Gardner M; Hansen RA; Farmer B; Baris BA; Henrich WL
    J Am Soc Nephrol; 1995 Aug; 6(2):242-7. PubMed ID: 7579091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End-Stage Renal Disease Requiring Hemodialysis.
    Zomorodi K; Chen D; Lee L; Lasseter K; Marbury T
    J Clin Pharmacol; 2019 Aug; 59(8):1120-1129. PubMed ID: 30865315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate.
    Maia J; Almeida L; Falcão A; Soares E; Mota F; Potgieter MA; Potgieter JH; Soares-da-Silva P
    Int J Clin Pharmacol Ther; 2008 Mar; 46(3):119-30. PubMed ID: 18397682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open-label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal function.
    Johnson FK; Mudd PN; DiMino T; Vosk J; Sitaraman S; Boudes P; France N; Barlow C
    Clin Pharmacol Drug Dev; 2015 Jul; 4(4):256-61. PubMed ID: 27136905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition of guanadrel in subjects with normal and impaired renal function.
    Halstenson CE; Opsahl JA; Abraham PA; Schwenk MH; Andreadis NA; Antal EJ; Matzke GR
    J Clin Pharmacol; 1989 Feb; 29(2):128-32. PubMed ID: 2715368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment
.
    Min KC; Lasseter KC; Marbury TC; Wrishko RE; Hanley WD; Wolford DG; Udo de Haes J; Reitmann C; Gutstein DE
    Int J Clin Pharmacol Ther; 2017 Sep; 55(9):746-752. PubMed ID: 28679468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Dorr MB; Johnson RD; Jensen B; Magner D; Marbury T; Talbot GH
    Clin Ther; 1999 Jul; 21(7):1202-15. PubMed ID: 10463518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of rosiglitazone in patients with varying degrees of renal insufficiency.
    Chapelsky MC; Thompson-Culkin K; Miller AK; Sack M; Blum R; Freed MI
    J Clin Pharmacol; 2003 Mar; 43(3):252-9. PubMed ID: 12638393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis.
    Chen N; Lau H; Kong L; Kumar G; Zeldis JB; Knight R; Laskin OL
    J Clin Pharmacol; 2007 Dec; 47(12):1466-75. PubMed ID: 17954615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
    Shah A; Lettieri J; Blum R; Millikin S; Sica D; Heller AH
    J Antimicrob Chemother; 1996 Jul; 38(1):103-16. PubMed ID: 8858462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steady state pharmacokinetics and dose equivalents of oral clodronate in renal failure.
    Mäkelä S; Saha H; Ala-Houhala I; Liukko-Sipi S; Ylitalo P
    Int J Clin Pharmacol Ther; 2011 Feb; 49(2):128-36. PubMed ID: 21255529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of renal impairment on disposition of pentopril and its active metabolite.
    Rakhit A; Radensky P; Szerlip HM; Kochak GM; Audet PR; Hurley ME; Feldman GM
    Clin Pharmacol Ther; 1988 Jul; 44(1):39-48. PubMed ID: 3391004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cefuroxime axetil in patients with normal and impaired renal function.
    Konishi K; Suzuki H; Hayashi M; Saruta T
    J Antimicrob Chemother; 1993 Mar; 31(3):413-20. PubMed ID: 8486575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of the combination of ticarcillin with clavulanic acid in renal insufficiency.
    Dalet F; Amado E; Cabrera E; Donate T; del Rio G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():57-64. PubMed ID: 3722047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.